Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.3%
5Y CAGR+33.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+31.3%/yr
vs +186.3%/yr prior
5Y CAGR
+33.7%/yr
Consistent
Acceleration
-155.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $443.21M | +29.3% |
| 2024 | $342.85M | +38.0% |
| 2023 | $248.49M | +26.8% |
| 2022 | $195.91M | +2.8% |
| 2021 | $190.65M | +83.9% |
| 2020 | $103.67M | +89.4% |
| 2019 | $54.74M | +1777.3% |
| 2018 | $2.92M | - |